日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release

一种靶向 Claudin 18.2 的亲和力调节型 T 细胞衔接器显示出强大的抗肿瘤活性,且细胞因子释放有限

Miguel Gaspar # ,Marina Natoli # ,Laure Castan ,Sharif Rahmy ,Martin Korade 3rd ,Cathryn Kelton ,Kathy Mulgrew ,Oisin Huhn ,D Gareth Rees ,Anna Sigurdardottir ,Christopher Lloyd ,Jonathan J Taylor ,Phillip M Brailey ,Laura Dallaway ,Aleksandra Toloczko ,Nicolas Giraldo ,Maria A S Broggi ,Andrew Kunihiro ,Sudhanshu Abhishek ,Yun He ,Yiping Rong ,Jim Eyles ,Kathryn Ball ,Jonathan Fitzgerald ,Scott A Hammond ,Saso Cemerski ,Simon J Dovedi ,Mark Cobbold

Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes

使用嵌合人类 E2 泛素结合酶进行靶向蛋白质降解

Jonathan D Taylor, Nathalie Barrett, Sergio Martinez Cuesta, Katelyn Cassidy, Fiona Pachl, James Dodgson, Radhika Patel, Tuula M Eriksson, Aidan Riley, Matthew Burrell, Christin Bauer, D Gareth Rees, Raffaello Cimbro, Andrew X Zhang, Ralph R Minter, James Hunt, Sandrine Legg

A simeprevir-inducible molecular switch for the control of cell and gene therapies

一种由西美普韦诱导的分子开关,用于控制细胞和基因治疗

Stacey E Chin,Christina Schindler,Lisa Vinall,Roger B Dodd,Lisa Bamber,Sandrine Legg,Anna Sigurdardottir,D Gareth Rees,Tim I M Malcolm,Samantha J Spratley,Cecilia Granéli,Jonathan Sumner,Natalie J Tigue

Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction

Tozorakimab (MEDI3506):一种抗 IL-33 抗体,可抑制 IL-33 通过 ST2 和 RAGE/EGFR 发出信号,从而减少炎症和上皮功能障碍

Elizabeth England #, D Gareth Rees #, Ian Christopher Scott #, Sara Carmen, Denice T Y Chan, Catherine E Chaillan Huntington, Kirsty F Houslay, Teodor Erngren, Mark Penney, Jayesh B Majithiya, Laura Rapley, Dorothy A Sims, Claire Hollins, Elizabeth C Hinchy, Martin D Strain, Benjamin P Kemp, Dominic

In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region

通过插入扫描诱变整个抗体可变区来体外进化抗体亲和力

Kalliopi Skamaki, Stephane Emond, Matthieu Chodorge, John Andrews, D Gareth Rees, Daniel Cannon, Bojana Popovic, Andrew Buchanan, Ralph R Minter, Florian Hollfelder

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses

人源化效应子缺失的 FcγRIIA 抗体可抑制免疫复合物介导的促炎反应

Bo Chen, Katherine A Vousden, Brian Naiman, Sean Turman, Hong Sun, Shu Wang, Lisa M K Vinall, Benjamin P Kemp, Srinath Kasturiangan, D Gareth Rees, Ethan Grant, Mary Jane Hinrichs, Steven Eck, Antonio DiGiandomenico, M Jack Borrok, Neang Ly, Ximing Xiong, Carlos Gonzalez, Christopher Morehouse, Yue

A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding

通过同时设计亲和力、选择性、稳定性和 FcRn 结合,实现具有优异体内疗效的 CD80 偏向性 CTLA4-Ig 融合蛋白

Julie Douthwaite, Jacques Moisan, Cyril Privezentzev, Blagoje Soskic, Shereen Sabbah, Suzanne Cohen, Andie Collinson, Elizabeth England, Catherine Huntington, Ben Kemp, Li Zhuang, Suzanne Hudak, D Gareth Rees, Debbie Goldberg, Chris Barton, Linda Chang, Inna Vainshtein, Meina Liang, Laurie Iciek, Ph

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential

MEDI1873,一种强效、稳定的人类 GITR 六聚体激动剂,具有调节性 T 细胞靶向潜力

Natalie J Tigue, Lisa Bamber, John Andrews, Samantha Ireland, James Hair, Edward Carter, Sudharsan Sridharan, Jelena Jovanović, D Gareth Rees, Jeremy S Springall, Emilie Solier, Yi-Ming Li, Matthieu Chodorge, David Perez-Martinez, Daniel R Higazi, Michael Oberst, Maureen Kennedy, Chelsea M Black, Li

Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation

IL-33报警素的氧化调节ST2依赖性炎症

E Suzanne Cohen,Ian C Scott,Jayesh B Majithiya,Laura Rapley,Benjamin P Kemp,Elizabeth England,D Gareth Rees,Catherine L Overed-Sayer,Joanne Woods,Nicholas J Bond,Christel Séguy Veyssier,Kevin J Embrey,Dorothy A Sims,Michael R Snaith,Katherine A Vousden,Martin D Strain,Denice T Y Chan,Sara Carmen,Catherine E Huntington,Liz Flavell,Jianqing Xu,Bojana Popovic,Christopher E Brightling,Tristan J Vaughan,Robin Butler,David C Lowe,Daniel R Higazi,Dominic J Corkill,Richard D May,Matthew A Sleeman,Tomas Mustelin

Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity

使用噬菌体和核糖体展示技术进行抗体 VH 和 VL 重组,揭示了亲和力改善的不同结构途径,其中 VH-VL 界面残基提供了重要的结构多样性

Maria A T Groves, Lily Amanuel, Jamie I Campbell, D Gareth Rees, Sudharsan Sridharan, Donna K Finch, David C Lowe, Tristan J Vaughan